Loading
Pooled across 36 studies, 20,366 people who had had cancer and 157,603 controls, 33.8 per cent of those who had had cancer were unemployed against 15.2 per cent, a relative risk of 1.37. Of four kinds of return-to-work programme tested in trials, exercise and multidisciplinary ones each raised the proportion returning by about a quarter; education alone did not.
The size of the problem. A meta-analysis and meta-regression pooled 36 studies published between 1966 and 2008, 16 from the United States, 15 from Europe and 5 elsewhere, covering 20,366 people who had had cancer and 157,603 healthy controls. Overall, 33.8 per cent of survivors were unemployed against 15.2 per cent of controls, a pooled relative risk of 1.37 (95 per cent confidence interval 1.21 to 1.55). By cancer: breast 35.6 against 31.7 per cent (relative risk 1.28), gastrointestinal cancers 48.8 against 33.4 per cent (1.44), cancers of the female reproductive organs 49.1 against 38.3 per cent (1.28). Three groups showed no significant excess: blood cancers (30.6 against 23.7 per cent, 1.41 with a confidence interval crossing one), prostate cancer (39.4 against 27.1 per cent, 1.11) and testicular cancer (18.5 against 18.1 per cent, 0.94). The meta-regression examined cancer type, country, average age at diagnosis and the background unemployment rate as explanations for the variation between studies.
What changes it. The Cochrane review of non-medical interventions, updated in 2024, included 15 randomised trials covering 1,477 people. All were conducted in high-income countries and most concerned breast cancer (nine trials) or prostate cancer (two). Nine trials were judged at low risk of bias and six at high risk, most often because of a lack of blinding, which is difficult to avoid in this kind of trial.
The results by type of programme, with the review's own certainty ratings:
Psycho-educational interventions, meaning patient education and counselling: "probably result in little to no difference in RTW compared to care as usual", relative risk 1.09 (0.96 to 1.24), 4 trials, 512 participants, moderate-certainty evidence. About 625 per 1,000 participants returned to work in both arms.
Vocational interventions: one trial of 34 participants, relative risk 0.94 (0.78 to 1.13), very low-certainty evidence. The review's phrase is "The evidence was very uncertain", which is the honest summary of a single trial of 34 people.
Physical interventions, meaning walking, yoga or structured exercise: "likely increase RTW compared to care as usual", relative risk 1.23 (1.08 to 1.39), 4 trials, 434 participants, moderate certainty. Translated by the review into absolute terms, probably 677 to 871 per 1,000 returned against 627 per 1,000 in the control group.
Multidisciplinary interventions, combining vocational counselling, education, counselling and physical exercise: "likely increase RTW", relative risk 1.23 (1.09 to 1.33), 6 trials, 497 participants, moderate certainty, which is 694 to 844 per 1,000 against 625 per 1,000.
Quality of life did not improve in any of the comparisons that measured it, with differences on the standard cancer quality-of-life questionnaire of 1.8 points and 1.4 points on a 100-point scale, both with confidence intervals crossing zero. That is worth stating directly: these programmes get more people back to work and have not been shown to make them feel better, and both halves of that matter when deciding whether to join one.
What this means practically. The thing with the best evidence is the same thing that has the best evidence for fatigue, strength and, in colon cancer, survival: structured exercise, which has its own record in this front with the dose written down. A programme that combines exercise with vocational counselling does about as well. A leaflet and a conversation, on the current evidence, does not.
What is missing, and it is a lot. Every trial was in a high-income country, so there is no evidence at all on return to work after cancer in low- and middle-income settings, where informal employment and the absence of sick pay make the question sharper. Two thirds of the trials were in breast or prostate cancer. The outcome measured is usually whether a person returned at 12 months, not whether they stayed, whether they returned to the same job, or whether they returned on terms they could sustain. And none of this literature covers self-employment, which is the situation in which a cancer diagnosis most directly removes income.
Return to work after cancer is limited by capacity and by arrangement, in that order. Fatigue, deconditioning, cognitive change and treatment schedules set what a person can do; hours, duties, travel and the employer's willingness to adjust set whether what they can do is enough for the job they have. Programmes built only on information address neither, which is consistent with the trial evidence that education alone changes nothing while exercise and multidisciplinary programmes change something.
Query for this technology: (TITLE:"Going back to work after cancer: the rates, and the programmes that change them" OR ABSTRACT:"Going back to work after cancer: the rates, and the programmes that change them") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Going back to work after cancer: the rates, and the programmes that change them, not a curated reading list.
Shares Fatigue after cancer treatment: what actually works, Cancer-related fatigue (tiredness), The exercise prescription after cancer: the dose the guidelines state, Quality of life and the tags rejuvenation, survivorship, psychosocial.
Shares Write a rehabilitation prescription at the end of treatment, and fund it like a drug, Living with a stoma, and living after an amputation, Rehabilitation is recommended everywhere and commissioned almost nowhere, Quality of life and the tags rejuvenation, survivorship, psychosocial.
Shares Employment rights with cancer in the United States, Employment rights with cancer in the United Kingdom, Money after treatment: what the cost of cancer does once the treatment has finished, Financial toxicity and the tags rejuvenation, survivorship, psychosocial.
Shares Testicular germ cell tumours, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it, Quality of life, Survivorship care and late-effects surveillance and the tags rejuvenation, survivorship, psychosocial.
Shares Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it, Quality of life, Survivorship care and late-effects surveillance, Late effects and survivorship toxicity and the tags rejuvenation, survivorship, psychosocial.
Shares The exercise prescription after cancer: the dose the guidelines state, Testicular germ cell tumours, Quality of life, Late effects and survivorship toxicity and the tags rejuvenation, survivorship, psychosocial.
Shares Money after treatment: what the cost of cancer does once the treatment has finished, Quality of life, Survivorship care and late-effects surveillance, Survivorship and late effects are neglected and the tags rejuvenation, survivorship, psychosocial.
Shares Quality of life, Survivorship care and late-effects surveillance, Survivorship and late effects are neglected, Hodgkin lymphoma and the tags rejuvenation, survivorship, psychosocial.